Alcohol, Stress and the Brain

Similar documents
Novel Targets for Treatment from the Dark Side of Dependence: Focus on the Brain Stress Systems

The Relationship Between the Reward and Stress Systems and How They are Perturbed in Addiction

Causes of Alcohol Abuse and Alcoholism: Biological/Biochemical Perspectives

American Society of Addiction Medicine

The Neurobiology of Addiction. An Overview

DSM-IV Alcohol Dependence. Alcohol and Drug Abuse. Screening for Alcohol Risk. DSM-IV Alcohol Abuse

Neuroadaptive mechanisms of addiction: studies on the extended amygdala

Brain Damage & Recovery: The Resilience of the Brain, Addiction Impact & Therapeutic Repair. Michael Fishman, MD Director of Young Adult Program

Neurobiology and Treatment of Alcohol Dependence. Nebraska MAT Training September 29, 2011

Overview. Unit 5: How do our choices change our brains?

Introduction to Tolerance, Physical Dependence and Withdrawal

NEUROPHARMACOLOGY AND ADDICTION CHRISTOPHER M. JONES, PHARMD, MPH

Alcoholism, like addiction to other drugs, is a chronic, THE POTENTIAL OF NEUROSCIENCE TO INFORM TREATMENT. George F. Koob, Ph.D.

Drug Addiction, Dysregulation of Reward, and Allostasis George F. Koob, Ph.D., and Michel Le Moal, M.D., Ph.D.

WHAT HAPPENS TO OUR BRAIN?

The Limbic System Theory of Addiction

What Can Science Contribute to the Treatment of Alcoholism?

Relationship Between Stress and Substance Use Disorders: Neurobiologic Interface

Drugs, The Brain, and Behavior

12 Steps to Changing Neuropathways. Julie Denton

Identification, treatment and support for individuals with Alcohol & Drug Addiction in the Community

The Addicted Brain. And what you can do

Health on the Homefront: PTSD, Its Clinical Description, Treatment and Underlying Pathophysiology

Tolerance and Dependence

The Science of Addiction:

Source: National Institute on Alcohol Abuse and Alcoholism. Bethesda, Md: NIAAA; NIH Publication No

Drug Discovery for the Treatment of Addiction. Medicinal Chemistry Strategies

Source: National Institute on Alcohol Abuse and Alcoholism. Bethesda, Md: NIAAA; NIH Publication No

The Brain, Behavior, and Addiction. Objectives. Advances in science have revolutionized our fundamental views of drug abuse and addiction.

The latest in addiction medicine: What every nurse needs to know

1. According to recent US national estimates, which of the following substances is associated

7/29/2013. Pleasure Unwoven: An Adventure in Social Marketing. Choice vs. Disease. Kevin McCauley, MD Texas Behavioral Health Insistute July 2013

The Future of Treating Alcoholism: Framing the Key Research Questions

Chronic Stress, Drug Use, and Vulnerability to Addiction

Slide 1: Introduction Introduce the purpose of your presentation. Indicate that you will explain how the brain basically works and how and where

Addiction Neurobiology

SC 215 FIGHTING DRUG ADDICTION WITH DRUGS. John Bush April 15, 2013

THE BRAIN & DRUGS. Nebraska Training on Substance Abuse Prevention

Kathleen T. Brady, M.D., Ph.D., and Susan C. Sonne, Pharm.D.

Alcohol Overuse and Abuse

Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )

Alcohol withdrawal A challenge in caring for patients after heart surgery

Alcohol Withdrawal Syndrome & CIWA Assessment

Integration and Coordination of the Human Body. Nervous System

Prevention & Recovery Conference November 28, 29 & 30 Norman, Ok

Chapter Fourteen. Emotion, Reward, Aggression, and Stress

Understanding Addiction: The Intersection of Biology and Psychology

Diseases of the Nervous System. Neal G. Simon, Ph.D. Professor, Dept of Biological Sciences Lehigh University

AMPHETAMINE AND COCAINE MECHANISMS AND HAZARDS

Drug dependence: stress and dysregulation of brain reward pathways

Beroendemekanismer- ett beroende som andra?

ADOLESCENT BRAIN DEVELOPMENT: IMPLICATIONS FOR DRUG USE PREVENTION. Jessie Breyer, B.A. & Ken C. Winters, Ph.D. Center for Substance Abuse Research

substance abuse and addiction are complex phenomena

The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction

Addictions: Why Don t They Just Quit?

Dependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania

RECENT ADVANCES IN ANIMAL MODELS OF DRUG ADDICTION

Stress and Cocaine Addiction

Why Meditation is successful in Substance abuse treatment. Mediation paired with substance abuse treatment has been around since 1982 when the

The Cranium Connection

PSK171 STRESS MANAGEMENT

EPIDEMIC 4.6 % OF INDIVIDUALS USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.

Stress Psychophysiology. Introduction. The Brain. Chapter 2

LESSON 5.7 WORKBOOK Is addiction a chronic disease?

Response to Stress Graphics are used with permission of: Pearson Education Inc., publishing as Benjamin Cummings (

States of Consciousness Notes

The Neuropharmacology of Drugs of Abuse 3

While the individual patient, rather than his or her disease, is the appropriate

Sponsored by: 2013 NAMI Maryland Conference Baltimore, Maryland; Friday, October 18 th, 2013

ASSIGNMENTS AND GRADING

Addiction Medicine 2014

Robert Walker, M.S.W., L.C.S.W., Assistant Professor University of Kentucky

NEUROBIOLOGY OF CANNABIS ADDICTION Part I

The neuroscience of depression: why does it matter? Dr Susan Mizen Exeter

OVERVIEW OF MEDICATION ASSISTED TREATMENT

Neural Systems Involved in Food Intake: An Integrative Overview

Advanced Treatment for Opioid & Alcohol Dependence. John Larson, M.D. Corporate Medical Director Gateway Foundation

Martha Brewer, MS, LPC,LADC. Substance Abuse and Treatment

How To Know If You Can Get Over Your Head With Exercise

MOLECULAR AND CELLULAR BIOLOGY OF ADDICTION

John Littleton, MD, Ph.D.

Addiction and Trauma 3 rd Annual Co-Occurring Disorders Institute June 9, 2011

Understanding Addiction: Squirrel Logic

Addiction: The New Definition from the American Society of Addiction Medicine (ASAM)

Transcription:

Alcohol, Stress and the Brain George F. Koob, Ph.D. Professor and Chair Committee on the Neurobiology of Addictive Disorders The Scripps Research Institute La Jolla, California Koob GF, A Role for Brain Stress Systems in Addiction, Neuron 59 (2008) 11-34 Koob, G. F. and Volkow. N. D. Neurocircuitry of Addiction, Neuropsychopharmacology reviews 35 (2010) 217-238

Stress definition "Stress is the nonspecific (common) result of any demand upon the body" from: Selye H, Selye's Guide to Stress Research, Van Nostrand Reinhold, New York, 1990. "Stress is anything which causes an alteration of psychological homeostatic processes" from: Burchfield SR, Psychosom Med, 1979, 41:661-672.

I saw Kazak out of the corner of my right eye. His eyes were pinwheels. His teeth were white daggers. His slobber was cyanide. His blood was nitroglycerine. He was floating toward me like a zeppelin, hanging lazily in the air. My eyes told my mind about him. My mind sent a message to my hypothalamus, told it to release the hormone CRF into the short vessels connecting my hypothalamus and my pituitary gland. The CRF inspired my pituitary gland to dump the hormone ACTH into my bloodstream. My pituitary had been making and storing ACTH for just such an occasion. And nearer and nearer the zeppelin came. And some of the ACTH in my bloodstream reached the outer shell of my adrenal gland, which had been making and storing glucocorticoids for emergencies. My adrenal gland added the glucocorticoids to my bloodstream. They went all over my body, changing glycogen into glucose. Glucose was muscle food. It would help me fight like a wildcat or run like a deer. And nearer and nearer the zeppelin came. My adrenal gland gave me a shot of adrenaline, too. I turned purple as my blood pressure skyrocketed. The adrenaline made my heart go like a burgler alarm. It also stood my hair on end. It also caused coagulants to pour into my bloodstream, so in case I was wounded, my vital juices wouldn t drain away. Everything my body had done so far fell within normal operating procedures for a human machine. But my body took one defensive measure which I am told was without precedent in medical history. It may have happened because some wire shortcircuited or some gasket blew. At any rate, I also retracted my testicles into my abdominal cavity, pulled them into my fuselage like the landing gear of an airplane. And now they tell me that only surgery will bring them down again. Breakfast of Champions by Kurt Vonnegut

Brain Actions of Corticotropin-Releasing Factor (CRF)

Major CRF-Immunoreactive Cell Groups and Fiber Systems in the Rat Brain From: Swanson LW, Sawchenko PE, Rivier J and Vale W, Neuroendocrinology, 1983, 36:165-186.

CRF Produces Arousal, Stress-like Responses, and a Dysphoric, Aversive State Paradigm CRF Agonist CRF Antagonist Acoustic startle Facilitates startle Blocks fear-potentiated startle Elevated plus maze Suppresses exploration Reverses suppression of exploration Defensive burying Enhances burying Reduces burying Fear conditioning Induces conditioned fear Blocks acquisition of conditioned fear Cued electric shock Enhances freezing Attenuates freezing Taste / Place Conditioning Produces place aversion Weakens drug-induced place aversion

Theoretical Framework Relating Addiction Cycle to Motivation for Drug Seeking From: Koob GF. Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder. In: Spanagel R, Sommer W (eds) Behavioral Neurobiology of Alcohol Addiction (series title: Current Topics in Behavioral Neuroscience), Springer, New York, in press.

Positive and Negative Reinforcement- Definitions Positive Reinforcement defined as the process by which presentation of a stimulus (drug) increases the probability of a response (non dependent drug taking paradigms). Negative Reinforcement defined as a process by which removal of an aversive stimulus (negative emotional state of drug withdrawal) increases the probability of a response (dependence-induced drug taking)

Stages of the Addiction Cycle

Bottom lines 1. Addiction is a reward deficit disorder 2. Addiction is an S-R perseveration disorder 3. Addiction is a stress surfeit disorder 4. Addiction is a self-regulation disorder

Neurobiology of Addiction

Binge/Intoxication Stage From: Koob, G. F. and Volkow. N. D. Neurocircuitry of Addiction, Neuropsychopharmacology reviews 35 (2010) 217-238

Converging Acute Actions of Drugs of Abuse on the Ventral Tegmental Area and Nucleus Accumbens From: Nestler EJ, Nat Neurosci, 2005, 8:1445-1449.

Withdrawal/Negative Affect Stage Koob, G. F. and Volkow. N. D. Neurocircuitry of Addiction, Neuropsychopharmacology reviews 35 (2010) 217-238

Types of Withdrawal Somatic ( physical ) withdrawal- bodily signs Motivational ( psychic ) withdrawal- emotional signs

Somatic Withdrawal Different Somatic Signs for Different Drugs of Abuse Flu-like state, pain- Opioids Tremor, hyperthermia, seizures- Alcohol Increased appetite, Sleep disturbances- Nicotine

Motivational Withdrawal Common Elements Negative Emotional State Signs Anxiety Irritability Dysphoria Malaise Everything is gray Alexithymia- inability to express one s feelings Hyperkatifiea- hyper-negative emotional state

Standard Pattern of Affective Dynamics Produced by Novel and Repeated Unconditioned Stimulus From: Solomon RL, American Psychologist, 1980, 35:691-712.

Reward Transmitters Implicated in the Motivational Effects of Drugs of Abuse Positive Hedonic Effects Dopamine Opioid peptides Serotonin GABA Negative Hedonic Effects of Withdrawal Dopamine dysphoria Opioid peptides... pain Serotonin dysphoria GABA anxiety, panic attacks

CNS Actions of Corticotropin-Releasing Factor (CRF)

Anti-Reward Transmitters Implicated in the Motivational Effects of Drugs of Abuse Dynorphin dysphoria CRF stress Norepinephrine stress

Sampling of Interstitial Neurochemicals by in vivo Microdialysis Allows sampling of neurochemicals in conscious animals (correlate brain chemistry with behavior). Implanted so that semi-permeable probe tip is in specific brain region of interest. Substances below the membrane MW cutoff diffuse across membrane based on concentration gradient. Both neurochemical sampling and localized drug delivery are possible. Collaborators: Dr. Friedbert Weiss, Dr. Larry Parsons, Dr. Emilio Merlo-Pich, Dr. Regina Richter

Withdrawal-induced Increases in Extracellular Levels of CRF

Pieter Bruegel

Rodent Model of Excessive Drinking During Withdrawal Self-administration training Dependence induction Withdrawal from alcohol vapors Negative emotional state: Anxiety-like behavior Reward threshold deficits Increased CRF release in the extended amygdala Sweetened solution fading used to train animals to lever press for: 10%w/v EtOH vs Water Chronic intermittent alcohol vapors (4+ wks) Target blood alcohol levels (BALs): 0.125-0.250 g% Excessive drinking: 2-3 fold higher alcohol intake Increased progressive ratio breakpoints Relapse following prolonged abstinence Methods from: Roberts AJ, Cole M and Koob GF, Alcohol Clin Exp Res, 1996, 20:1289-1298. Roberts AJ, Heyser CJ, Cole M, Griffin P and Koob GF, Neuropsychopharmacology, 2000, 22:581-584. O Dell LE, Roberts AJ, Smith RT and Koob GF, Alcohol Clin Exp Res, 2004, 28:1676-1682.

CRF 1 Antagonist R121919 Decreases Excessive Ethanol Self-administration during Withdrawal (30 min session 2 h into withdrawal) From: Funk C, Zorrilla EP, Lee MJ, Rice KC and Koob GF, 2007, Biological Psychiatry 61:78-86.

CRF Antagonist D-Phe-CRF 12-41 in Central Nucleus of the Amygdala Decreases Ethanol Self-Administration During Withdrawal in Wistar Rats (30 min session 2 h into withdrawal) From: Funk C, O Dell LE and Koob GF,2006 J. Neuroscience 26:11324-11332.

CRF 1 R Antagonist Blocks Transition to Dependence-induced Drinking From: Roberto, Cruz, Gilpin, et al., Bological Psychiatry, 67 (2010) 831-839

Protracted Abstinence State of protracted abstinence in subjects with addiction or alcoholism weeks after acute withdrawal. Conceptualized as a state change characterized by anxiety and dysphoria or a residual negative emotional state that combines with drug or cueexposure to produce relapse to excessive drug taking Animal models of protracted abstinence include increased sensitivity to stressors and increased drug taking in animals during protracted abstinence Neurobiological substrates include residual activation of brain stress systems including corticotropin releasing factor in the extended amygdala

Effect of Mild Stress on Anxiogenic-Like Behavior in the Elevated Plus Maze In Animals with a History of Dependence

CRF=1 antagonist selectively suppresses alcohol self-administration in post-dependent animals (Hansson et al, PNAS 2006; Gehlert et al, J Neurosci 2007) 60 50 control # post-dependent Responses / 30 min 40 30 20 10 ** 0 0 3 10 0 3 10 MTIP (mg/kg)

Role of Corticotropin-releasing Factor in Dependence Drug CRF antagonist effects on withdrawalinduced anxiety-like responses Withdrawalinduced changes in extracellular CRF in CeA CRF antagonist effects on dependence-induced increases in selfadministration CRF antagonist reversal of stress-induced reinstatement Cocaine Opioids * Ethanol Nicotine Δ 9 -tetrahydrocannabinol nt nt * = aversive effects with place conditioning. nt = not tested. CeA = central nucleus of the amygdala. From: Koob, G.F. 2008 Neuron 59:11-34

Chronic Glucocorticoid Receptor Blockade by Mifepristone Prevented Escalated Alcohol Intake and Motivation for Alcohol in Vapor-exposed Rats From: Vendruscolo LF, Barbier E, Schlosburg JE, Misra KK, Whitfield TW Jr, Logrip ML, Rivier C, Repunte-Canonigo V, Zorrilla EP, Sanna PP, Heilig M, Koob GF. unpublished results.

Chronic Glucocorticoid Receptor Blockade by Mifepristone Decreased Escalated Alcohol Intake in Vapor-exposed Rats During Protracted Abstinence From: Vendruscolo LF, Barbier E, Schlosburg JE, Misra KK, Whitfield TW Jr, Logrip ML, Rivier C, Repunte-Canonigo V, Zorrilla EP, Sanna PP, Heilig M, Koob GF. unpublished results.

HPA Axis, Extrahypothalamic Glucocorticoid Receptors, and Brain Stress/Reward Function Recruited at Different Stages of Addiction Cycle From: Vendruscolo LF, Barbier E, Schlosburg JE, Misra KK, Whitfield TW Jr, Logrip ML, Rivier C, Repunte-Canonigo V, Zorrilla EP, Sanna PP, Heilig M, Koob GF. unpublished results.

Non-dependent Positive Reinforcement Negative Reinforcement Dependent

Brain Arousal-Stress System Modulation in the Extended Amygdala From: Koob, G.F. 2008 Neuron 59:11-34

Stress and Anti-stress Neurotransmitters Implicated in the Motivational Effects of Drugs of Abuse Corticotropin-releasing factor Neuropeptide Y Norepinephrine Nociceptin (orphanin FQ) Vasopressin Orexin (hypocretin) Dynoprhin Substance P

Neurobiology of Addiction: Preoccupation- Anticipation ( Craving ) Stage From: Koob, G. F. and Volkow. N. D. Neurocircuitry of Addiction, Neuropsychopharmacology reviews 35 (2010) 217-238

Loss of Control Over Intake Self-medication Cause Neuron/oligodendrocyte death VTA CRF Neurons? PFC DA/NE? Initial intake PFC CRF/GABA interneurons Withdrawal

Neuroplasticity in Brain Circuits associated with the Development of Addiction- Revised

Key Findings and Conclusions Acute reinforcing effects of drugs of abuse depend on neurochemical substrates such as GABA, opioid peptides, serotonin, glutamate and dopamine in the ventral striatum of the basal forebrain. Acute withdrawal from all major drugs of abuse produces decreases in reward function, increases in stress-like responses and increases in CRF in the amygdala that are of motivational significance Craving (Preoccupation/anticipation stage of addiction cycle)-- involves a significant cortical glutamate system dysregulation and a brain stress component also mediated by CRF systems in the extended amygdala Compulsive drug use associated with dependence is mediated by not only loss of function of reward systems but recruitment of brain stress systems such as corticotropin releasing factor, norepinephrine and dynorphin in the extended amygdala Brain-arousal stress systems in the extended amygdala--- may be key components of not only for the negative emotional states that drive dependence on drugs of abuse but also may overlap with the negative emotional components of other psychopathologies